Condition: Prostate Cancer · Sponsor: Chinese University of Hong Kong
This study is to investigate the efficacy of Targeted Microwave Ablation (TMA) under MRI-Ultrasound fusion and organ-based tracking (OBT) navigation in localized prostate cancer (PCa) in a multi-centre trial.
This description comes directly from the study's public registry record.
Peter Ka-Fung CHIU, PhD,MBChB · 35052625 · peterchiu@surgery.cuhk.edu.hk
Always discuss trial participation with your own doctor first.
| Peter Ka-Fung CHIU | Shatin, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06262633